Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2012 1
2015 7
2016 5
2017 4
2018 1
2019 3
2020 6
2021 9
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Popek-Marciniec S, Zmorzyński S, Koczkodaj D, Marciniec M, Wąsik-Szczepanek E, Karczmarczyk A, Michalak-Wojnowska M, Filip A. Popek-Marciniec S, et al. Among authors: karczmarczyk a. Acta Haematol. 2023;146(4):277-286. doi: 10.1159/000526397. Epub 2023 Apr 4. Acta Haematol. 2023. PMID: 37015191
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia.
Szelest M, Masternak M, Zając M, Chojnacki M, Skórka K, Zaleska J, Karczmarczyk A, Stasiak G, Wawrzyniak E, Kotkowska A, Siemieniuk-Ryś M, Purkot J, Subocz E, Cichocka E, Tomczak W, Zawirska D, Giannopoulos K. Szelest M, et al. Among authors: karczmarczyk a. PLoS One. 2022 Oct 25;17(10):e0276674. doi: 10.1371/journal.pone.0276674. eCollection 2022. PLoS One. 2022. PMID: 36282861 Free PMC article.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia.
Giannopoulos K, Karczmarczyk A, Karp M, Bojarska-Junak A, Kosior K, Kowal M, Tomczak W, Hus M, Machnicki M, Stokłosa T. Giannopoulos K, et al. Among authors: karczmarczyk a. Oncol Lett. 2021 Apr;21(4):285. doi: 10.3892/ol.2021.12546. Epub 2021 Feb 12. Oncol Lett. 2021. PMID: 33732361 Free PMC article.
39 results